Quest for a cure: potential small-molecule treatments for COVID-19, part 2

DL Hughes - Organic Process Research & Development, 2021 - ACS Publications
During the first year of the outbreak of the COVID-19 pandemic, many drugs and drug
candidates have been evaluated as treatment options. None yet has proved to be an …

Nanostructures for the Prevention, Diagnosis, and Treatment of COVID‐19: A Review

Z Tavakoli, F Ranjbar, SH Tackallou… - Particle & Particle …, 2024 - Wiley Online Library
Viral infections are a significant cause of death globally, resulting in substantial ethical,
social, and economic costs. In recent years, the world has experienced the worst epidemic of …

Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19

J Wang, J Levi, L Ellis, A Hill - MedRxiv, 2021 - medrxiv.org
Background Currently, only dexamethasone, tocilizumab and sarilumab have conclusively
been shown to reduce mortality of COVID-19. No drug for prevention or treatment in earlier …

Spectroscopic and Chromatographic Method Development and Validation for the estimation of Antimicrobial Agents and their combinations in Synthetic Mixture and …

YU Pandya, RP Samixa - 2022 - library.atmiya.net
Background: The present research work comprises of the Stability Indicating RP-HPLC
newlineanalytical method development and validation for selected drugs andamp; …

[HTML][HTML] Cost of Goods Analysis Facilitates an Integrated Approach to Identifying Alternative Synthesis Methodologies for Lower Cost Manufacturing of the COVID-19 …

C Peterson, S Paria, A Deshpande, S Ahmad… - Gates Open …, 2022 - ncbi.nlm.nih.gov
Orally delivered drugs offer significant benefits in the fight against viral infections, and cost-
effective production is critical to their impact on pandemic response in low-and middle …